Clinical safety and efficacy of endothermic needle soft tissue therapy device for myofascial pain syndromes Randomized, single-blind, multicenter, parallel controlled clinical trials

A randomized, single-blind, multicenter, parallel controlled clinical trial of the clinical safety and efficacy of endothermic needle soft tissue therapy for the treatment of myofascial pain syndrome

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000040068

Enrollment

Unknown

Registered

2020-11-20

Start date

2020-12-01

Completion date

Unknown

Last updated

2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myofascial pain syndrome

Interventions

experimental group:TN-32C endothermic needle therapy instrument

control group:KF type endothermic acupuncture treatment instrument

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Meet the clinical diagnostic criteria for myofascial pain syndrome with a duration of more than 3 months; (2) Agreeing to participate in treatment without other massage, physical therapy, acupuncture, or other treatments. (3) Ages 18 to 80 (including 18 and 80), regardless of gender; (4) VAS score >=4; (5) Sign an informed consent or have a legally authorized representative sign an informed consent.

Exclusion criteria

Exclusion criteria: 1. Severe cardiovascular and cerebrovascular disease and liver, lung and kidney failure; 2. Coexistence of other serious illnesses, epilepsy, mental illness, severe depression, alcoholism and other serious illnesses dependents. 3. In case of pregnancy and severe anemia, blood HCG should be checked in female subjects of childbearing age if pregnancy cannot be excluded; 4. Persons with coagulation abnormalities; 5. Persons with localized skin allergies or infectious diseases; 6. Persons with fever; 7. Patients who have used the same treatment within the past month; 8. Other unsuitable and uncooperative persons.

Design outcomes

Primary

Measure	Time frame
Quality of Life;	—

Countries

China

Contacts

Public ContactLi Rongchun

Wuhan Fourth Hospital

lrcpayyttk@163.com+86 1311434690

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026